## Abstract ## BACKGROUND The clinical value of positron emission tomography (PET) with [^18^F]fluoro‐2‐deoxy‐D‐glucose (FDG) for primary staging in cervical carcinoma appears to be promising. The authors sought to evaluate the diagnostic efficacy and benefit of PET in restaging cervical carcinoma
Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose–positron emission tomography
✍ Scribed by Jason D. Wright; Farrokh Dehdashti; Thomas J. Herzog; David G. Mutch; Phyllis C. Huettner; Janet S. Rader; Randall K. Gibb; Matthew A. Powell; Feng Gao; Barry A. Siegel; Perry W. Grigsby
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 166 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
^18^F‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography (FDG‐PET)/PET‐computed tomography diagnostic studies may play a potential role in the staging and restaging of patients with cervical cancer. Recent work has demonstrated another important aspect of FDG‐PET in predicting the prognosis for p
## BACKGROUND. Positron emission tomography (PET) with 2-deoxy-2-fluoro[ 18 F]-Dglucose (FDG) can provide quantitative information about tumor glucose metabolism. The prognostic value of this technique was evaluated for breast carcinoma patients. ## METHODS. FDG PET was performed on 70 patients w
## Abstract ## BACKGROUND. The authors conducted a comprehensive review of the efficacy of 2‐deoxy‐2‐[F‐18]fluoro‐D‐glucose positron emission tomography (FDG‐PET) in the detection of primary tumors in patients with disseminated carcinoma of unknown primary site. ## METHODS. Ten studies (involvin